iSpecimen Inc
ISPC1.550USD
+0.080+5.44%
Market hours （ET）Quotes delayed by 15 min
3.87MMarket Cap
LossP/E TTM
More Details of iSpecimen Inc Company
iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.
Company Info
Ticker SymbolISPC
Company nameiSpecimen Inc
IPO dateJun 17, 2021
CEOMr. Robert Bradley Lim
Number of employees24
Security typeOrdinary Share
Fiscal year-endJun 17
Address8 Cabot Road
CityWOBURN
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code08101
Phone17813016700
Websitehttps://www.ispecimen.com/
Ticker SymbolISPC
IPO dateJun 17, 2021
CEOMr. Robert Bradley Lim
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Mr. Yuying Liang
Mr. Yuying Liang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Mr. Yuying Liang
Mr. Yuying Liang
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
976.97K
92.38%
Shipping and other
80.54K
7.62%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Specimens – contracts with customers
976.97K
92.38%
Shipping and other
80.54K
7.62%
Shareholding Stats
Updated: Sun, Jul 27
Updated: Sun, Jul 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
OBF Investments LLC
1.69%
Wolf (James G)
1.01%
Bridgeway Capital Management, LLC
0.87%
UBS Financial Services, Inc.
0.87%
Geode Capital Management, L.L.C.
0.43%
Other
95.13%
Shareholders
Shareholders
Proportion
OBF Investments LLC
1.69%
Wolf (James G)
1.01%
Bridgeway Capital Management, LLC
0.87%
UBS Financial Services, Inc.
0.87%
Geode Capital Management, L.L.C.
0.43%
Other
95.13%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.93%
Corporation
1.69%
Individual Investor
1.02%
Investment Advisor/Hedge Fund
0.43%
Hedge Fund
0.12%
Other
94.82%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
31
129.44K
5.18%
-38.53K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
2023Q1
47
214.33K
47.61%
-27.06K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
OBF Investments LLC
42.10K
1.69%
+1.00
+0.00%
Dec 31, 2024
Wolf (James G)
25.25K
1.01%
-14.29K
-36.14%
Jun 03, 2024
Bridgeway Capital Management, LLC
21.80K
0.87%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
21.71K
0.87%
+10.74K
+97.84%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.73K
0.43%
+10.73K
--
Mar 31, 2025
Tower Research Capital LLC
2.98K
0.12%
+2.85K
+2175.57%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.11%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
1.80K
0.07%
--
--
May 31, 2025
Scholl (George H)
163.00
0.01%
+7.00
+4.49%
Dec 31, 2023
Brooks (John L III)
32.00
0%
-131.00
-80.37%
Apr 14, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Date
Type
Ratio
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
Sep 11, 2024
Merger
20<1
